Nuvectis Pharma Announces Upcoming Presentations at the 2023 American Association for Cancer Research Meeting

March 17, 2023

https://www.globenewswire.com/news-release/2023/03/17/2629448/0/en/Nuvectis-Pharma-Announces-Upcoming-Presentations-at-the-2023-American-Association-for-Cancer-Research-Meeting.html

Fort Lee, NJ, March 17, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ:NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP800 and NXP900 at the upcoming 2023 American Association for Cancer Research Meeting (2023 AACR), taking place from April 14th to April 19th in Orlando, Florida. Presentation details are below:

Read more at globenewswire.com

Related news for (NVCT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.